Hedge Fund Siren Adds $29 Million in Erasca Shares Despite Stock's 700% Surge
New York-based hedge fund Siren added a significant stake of nearly 2.5 million shares, valued at approximately $29.39 million, to its position in cancer-focused biopharma company Erasca (NASDAQ:ERAS). The move comes as the stock has surged by 700% over one year and now represents 5.04% of Siren's reported AUM.
Tickers: $ERAS